• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Minerva Anestesiol . Long-term effects of Coronavirus 2 infection after intensive care: a prospective study

tetano

Editor, Senior Moderator
Minerva Anestesiol


. 2022 Jul 14.
doi: 10.23736/S0375-9393.22.16728-3. Online ahead of print.
Long-term effects of Coronavirus 2 infection after intensive care: a prospective study


Vincenzo Damico[SUP] 1 [/SUP], Liana Murano[SUP] 2 [/SUP], Viola Margosio[SUP] 3 [/SUP], Niccolò Tognoni[SUP] 3 [/SUP], Alberto Dal Molin[SUP] 4 [/SUP], Erika Bassi[SUP] 4 [/SUP], Erica Busca[SUP] 4 [/SUP], Francesco Crimella[SUP] 3 [/SUP]



Affiliations

Abstract

Background: While the multi-organ manifestations of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection are now well-documented, the potential long-term implications of these manifestations remain to be uncovered. The aim was to study the level and predictors of post-traumatic stress, anxiety and depression symptoms, quality of life and functional disability in COVID-19 survivors during the first year post intensive care unit (ICU) discharge.
Methods: A prospective longitudinal study, reported following the STROBE guidance, was conducted in adult patients with SARS-CoV-2 infection admitted to an Italian ICU from March 2020 to March 2021 who were followed until March 2022.
Results: A total of 207 patients were included in the study, of which 145 (70.1%) were male. One hundred and six (51.2%) patients between six and 12 months after ICU discharge reported at least one physical or cognitive impairment. The concurrent prevalence of anxiety, depression and PTSD is present in 25/106 patients (23.6% of cases) at six months and increases in 29/106 patients (27.3% of cases) at 12 months. However, the prevalence of anxiety, depression and PTSD was observed in 86 patients (41.5%) at six months and it gets smaller in 78 patients (37.7%) at 12 months (p= .049). The EqVAS score (58.8 vs 72.3, p= .017) and the Barthel Index (61.5 vs 74.8, p< .001) increased significantly between six and 12 months after ICU.
Conclusions: Our results show that functional and cognitive recovery improves between six and 12 months after ICU discharge with a high perception of the patients' quality of life.
 
Back
Top Bottom